Eileen Danaher Hacker1, Anne M Fink, Tara Peters, Chang Park, Giamila Fantuzzi, Damiano Rondelli. 1. Author Affiliations: Department of Biobehavioral Health Science, College of Nursing (Drs Hacker and Fink, Ms Peters); Department of Health Science Systems, College of Nursing (Dr Park); Department of Kinesiology and Nutrition, College of Applied Health Sciences (Dr Fantuzzi); Department of Hematology/Oncology, College of Medicine (Dr Rondelli), University of Illinois at Chicago.
Abstract
BACKGROUND: Fatigue is highly prevalent after hematopoietic stem cell transplantation (HCT). It has been described as intense and may last for years following treatment. OBJECTIVE: The aim of this study is to compare fatigue, physical activity, sleep, emotional distress, cognitive function, and biological measures in HCT survivors with persistent fatigue (n = 25) with age- and gender-matched healthy controls with occasional tiredness (n = 25). METHODS: Data were collected using (a) objective, real-time assessments of physical activity and sleep over 7 days; (b) patient-reported fatigue assessments; (c) computerized objective testing of cognitive functioning; and (d) biological measures. Differences between groups were examined using multivariate analysis of variance. RESULTS: Survivors of HCT reported increased physical (P < .001), mental (P < .001), and overall (P < .001) fatigue as well as increased anxiety (P < .05) and depression (P < .01) compared with healthy controls. Red blood cell (RBC) levels were significantly lower in HCT survivors (P < .001). Levels of RBC for both groups, however, were in the normal range. Tumor necrosis factor-α (P < .001) and interleukin-6 (P < .05) levels were significantly higher in HCT survivors. CONCLUSIONS: Persistent fatigue in HCT survivors compared with healthy controls with occasional tiredness is accompanied by increased anxiety and depression along with decreased RBC counts. Elevated tumor necrosis factor-α and interleukin-6 levels may be important biomarkers. IMPLICATIONS FOR PRACTICE: This study provides preliminary support for the conceptualization of fatigue as existing on a continuum, with tiredness anchoring one end and exhaustion the other. Persistent fatigue experienced by HCT survivors is more severe than the occasional tiredness of everyday life.
BACKGROUND:Fatigue is highly prevalent after hematopoietic stem cell transplantation (HCT). It has been described as intense and may last for years following treatment. OBJECTIVE: The aim of this study is to compare fatigue, physical activity, sleep, emotional distress, cognitive function, and biological measures in HCT survivors with persistent fatigue (n = 25) with age- and gender-matched healthy controls with occasional tiredness (n = 25). METHODS: Data were collected using (a) objective, real-time assessments of physical activity and sleep over 7 days; (b) patient-reported fatigue assessments; (c) computerized objective testing of cognitive functioning; and (d) biological measures. Differences between groups were examined using multivariate analysis of variance. RESULTS: Survivors of HCT reported increased physical (P < .001), mental (P < .001), and overall (P < .001) fatigue as well as increased anxiety (P < .05) and depression (P < .01) compared with healthy controls. Red blood cell (RBC) levels were significantly lower in HCT survivors (P < .001). Levels of RBC for both groups, however, were in the normal range. Tumor necrosis factor-α (P < .001) and interleukin-6 (P < .05) levels were significantly higher in HCT survivors. CONCLUSIONS: Persistent fatigue in HCT survivors compared with healthy controls with occasional tiredness is accompanied by increased anxiety and depression along with decreased RBC counts. Elevated tumor necrosis factor-α and interleukin-6 levels may be important biomarkers. IMPLICATIONS FOR PRACTICE: This study provides preliminary support for the conceptualization of fatigue as existing on a continuum, with tiredness anchoring one end and exhaustion the other. Persistent fatigue experienced by HCT survivors is more severe than the occasional tiredness of everyday life.
Authors: Ann M Berger; Amy Pickar Abernethy; Ashley Atkinson; Andrea M Barsevick; William S Breitbart; David Cella; Bernadine Cimprich; Charles Cleeland; Mario A Eisenberger; Carmen P Escalante; Paul B Jacobsen; Phyllis Kaldor; Jennifer A Ligibel; Barbara A Murphy; Tracey O'Connor; William F Pirl; Eve Rodler; Hope S Rugo; Jay Thomas; Lynne I Wagner Journal: J Natl Compr Canc Netw Date: 2010-08 Impact factor: 11.908
Authors: Anne M Fink; Rosalia C Gonzalez; Tadeusz Lisowski; Maria Pini; Giamila Fantuzzi; Wayne C Levy; Mariann R Piano Journal: J Card Fail Date: 2012-09 Impact factor: 5.712
Authors: Daniel J Buysse; Lan Yu; Douglas E Moul; Anne Germain; Angela Stover; Nathan E Dodds; Kelly L Johnston; Melissa A Shablesky-Cade; Paul A Pilkonis Journal: Sleep Date: 2010-06 Impact factor: 5.849
Authors: Martine M Goedendorp; Marieke F M Gielissen; Constans A H H V M Verhagen; Gijs Bleijenberg Journal: J Pain Symptom Manage Date: 2012-08-25 Impact factor: 3.612
Authors: Ajay Sheshadri; Amin Alousi; Lara Bashoura; Karen Stolar; Shiva Baghaie; Muhammad H Arain; Laila Noor; Amulya Balagani; Akash Jain; David Blanco; Abel Ortiz; Susan K Peterson; Renee Langhals; Michael Taylor; Alex Stenzler; Rohtesh S Mehta; Uday R Popat; Chitra Hosing; Gabriela Rondon; Fan Shen; Liang Li; Guang-Shing Cheng; David E Ost; Richard E Champlin; Burton F Dickey Journal: Ann Am Thorac Soc Date: 2020-10
Authors: Erik Boberg; Nadir Kadri; Jeanette Winterling; Lindsay C Davies; Andreas Björklund; Mussie Msghina; Ellen Iacobaeus; Katarina Le Blanc Journal: Haematologica Date: 2019-10-24 Impact factor: 9.941
Authors: Eden R Brauer; Huibrie C Pieters; Patricia A Ganz; Wendy Landier; Carol Pavlish; MarySue V Heilemann Journal: J Adolesc Young Adult Oncol Date: 2017-06-08 Impact factor: 2.223
Authors: Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo Journal: Front Immunol Date: 2022-07-05 Impact factor: 8.786
Authors: Ashley M Nelson; Kelly A Hyland; Brent Small; Brittany Kennedy; Asmita Mishra; Aasha I Hoogland; Hailey W Bulls; Heather S L Jim; Paul B Jacobsen Journal: Ann Behav Med Date: 2021-08-23
Authors: Ajay Sheshadri; Sukh Makhnoon; Amin M Alousi; Lara Bashoura; Rene Andrade; Christopher J Miller; Karen R Stolar; Muhammad Hasan Arain; Laila Noor; Amulya Balagani; Akash Jain; David Blanco; Abel Ortiz; Michael S Taylor; Alex Stenzler; Rohtesh Mehta; Uday R Popat; Chitra Hosing; David E Ost; Richard E Champlin; Burton F Dickey; Susan K Peterson Journal: JMIR Form Res Date: 2022-02-07
Authors: Hayley T Dillon; Nicholas J Saner; Tegan Ilsley; David Kliman; Andrew Spencer; Sharon Avery; David W Dunstan; Robin M Daly; Steve F Fraser; Neville Owen; Brigid M Lynch; Bronwyn A Kingwell; Andre La Gerche; Erin J Howden Journal: BMC Cancer Date: 2022-08-17 Impact factor: 4.638